Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: An emerging treatment option for advanced goblet cell tumors of the appendix

Annals of Surgical Oncology

Volumn 21, Issue 6, 2014, Pages 1975-1982

  McConnell, Yarrow J ^a   Mack, Lloyd A ^a   Gui, Xianyong ^b   Carr, Norman J ^c   Sideris, Lucas ^d   Temple, Walley J ^a   Dubé, Pierre ^d   Chandrakumaran, Kandiah ^e   Moran, Brendan J ^e   Cecil, Tom D ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^e BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN; OXALIPLATIN; ANTINEOPLASTIC ANTIBIOTIC; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7;

ADULT; ADVANCED CANCER; APPENDIX CANCER; APPENDIX TUMOR; ARTICLE; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; FEMALE; GOBLET CELL TUMOR; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LONG TERM SURVIVAL; LYMPH NODE; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PERITONEUM CANCER; PROSPECTIVE STUDY; TREATMENT OUTCOME; ADENOCARCINOMA; APPENDICEAL NEOPLASMS; CARCINOID TUMOR; CHEMISTRY; DISEASE FREE SURVIVAL; HYPERTHERMIC THERAPY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; ANTIBIOTICS, ANTINEOPLASTIC; APPENDICEAL NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CARCINOID TUMOR; CYTOREDUCTION SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; KERATIN-20; KERATIN-7; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM GRADING; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84902208291     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3469-5     Document Type: Article

References (20)

1. Turaga KK, Pappas SG, Gamblin TC. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379-85.
2. McCusker ME, Coté TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer. 2002;94:3307-12.
3. Tang LH, Shia J, Soslow RA, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol. 2008;32:1429-43.
4. van Eeden S, Offerhaus GJA, Hart AAM, et al. Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology. 2007;51:763-73.
5. Alsaad KO, Serra S, Schmitt A, Perren A, Chetty R. Cytokeratins 7 and 20 immunoexpression profile in goblet cell and classical carcinoids of appendix. Endocr Pathol. 2007;18:16-22.
6. Jiang Y, Long H, Wang W, et al. Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix. Pathol Oncol Res. 2011;17:127-32.
7. Plöckinger U, Couvelard A, Falconi M, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinology. 2008;87:20-30.
8. Hristov AC, Young RH, Vang R, et al. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases. Am J Surg Pathol. 2007;31:1502-11.
9. Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449-56.
10. Chua TC, Yan TD, Smigielski ME, et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. J Clin Oncol. 2009;16:1903-11.
11. Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15:526-34.
12. El Halabi H, Gushchin V, Francis J, et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19:1-5.
13. Cashin P, Nygren P, Hellman P, et al. Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival. Clin Colorectal Cancer. 2011;10:108-12.
14. Mahteme H, Sugarbaker PH. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg. 2004;91:1168-73.
15. Bruin SC, Verwaal VJ, Vincent A, van't Veer LJ, van Velthuysen MLF. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol. 2010;17:2330-40.
16. Stewart JH, Shen P, Russell GB, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006;13:624-34.
17. Carr N, Sobin LH. Tumors of the appendix. In: Bosman F, Carneiro F, Hruban RH, et al, editors. Vol WHO classification of tumors of the digestive system. 4th ed. Lyon, France: IARC Press; 2010. pp 122-125.
18. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei." Am J Surg Pathol. 1995;19:1390-408.
19. Gilly FN, Cotte E, Brigand C, et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol. 2006;32:597-601.
20. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.